Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Pharm Res. 2012 Jul 14;29(12):3312–3324. doi: 10.1007/s11095-012-0823-4

Table 1.

Mean Tumor Microvessel Density

Days Post
Treatment
Control a (n b) SSL-DXR a (n b) p
4 87.9±2.8 (41) 60.8±1.7 (29) <0.0001
7 91.1±4.4 (39) 84.3c±5.1 (41) 0.3151
a

Mean microvessel density per field (± standard error of the mean) based on CD31 immunohistochemical staining

b

Number of fields analyzed; each sample set consisted of 3 animals per treatment group and 3 tissue sections analyzed for each animal

c

In SSL-DXR treatment group, the increase in microvessel density from day 4 to day 7 was significant (P<0.001)